drugset / Trial / NCT00492518

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy

NCT00492518

Phase 4 Completed 254 enrolled Technical University of Munich
RandomizedParallel-groupDouble-blindPrevention

Summary

Several studies demonstrated a significant reduction of contrast-induced nephropathy (CIN; definition: increase in serum creatinine of \>=0.5mg/dl and/or \>=25% increase within 48h after contrast-medium) by acetylcysteine (A) or theophylline (T). However, the results are contradictory. Therefore, it was the aim of our double-blind study to compare the effects of A, T, a combination of A and T (A+T), and placebo (P).

Timeline

Start
2002-02
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule
Subject Theophylline Small molecule